MicroRNA-214 protects cardiac myocytes against H2O 2-induced injury

Journal of Cellular Biochemistry

Volumn 115, Issue 1, 2014, Pages 93-101

  Lv, Guangwei ^a   Shao, Suxia ^a   Dong, Hua ^a   Bian, Xiaohua ^a   Yang, Xingwei ^a   Dong, Shimin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

APOPTOSIS; CARDIAC MYOCYTES; H2O2; MicroRNA 214; PHOSPHATASE AND TENSIN HOMOLOG (PTEN)

Indexed keywords

HYDROGEN PEROXIDE; MICRORNA 214; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REAL TIME POLYMERASE CHAIN REACTION; TARGET CELL; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CARDIAC MYOCYTES; H2O2; MICRORNA-214; PHOSPHATASE AND TENSIN HOMOLOG (PTEN);

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; MICRORNAS; MYOCYTES, CARDIAC; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84887959292     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24636     Document Type: Article

References (47)

1. Aikawa R, Nitta-Komatsubara Y, Kudoh S, Takano H, Nagai T, Yazaki Y, Nagai R, Komuro I,. 2002. Reactive oxygen species induce cardiomyocyte apoptosis partly through TNF-alpha. Cytokine 18: 179-183.
2. Almeida MI, Reis RM, Calin GA,. 2011. MicroRNA history: Discovery, recent applications, and next frontiers. Mutat Res 717: 1-8.
3. Ambros V,. 2004. The functions of animal microRNAs. Nature 431: 350-355.
4. Aurora AB, Mahmoud AI, Luo X, Johnson BA, van Rooij E, Matsuzaki S, Humphries KM, Hill JA, Bassel-Duby R, Sadek HA, Olson EN,. 2012. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J Clin Invest 122: 1222-1232.
5. Bartel DP,. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Berg K, Jynge P, Bjerve K, Skarra S, Basu S, Wiseth R,. 2005. Oxidative stress and inflammatory response during and following coronary interventions for acute myocardial infarction. Free Radic Res 39: 629-636.
7. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M, Autore C, Russo MA, Dorn GW II, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G,. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
8. Cerda S, Weitzman SA,. 1997. Influence of oxygen radical injury on DNA methylation. Mutat Res 386: 141-152.
9. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C,. 2007. MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy ? Am J Pathol 170: 1831-1840.
10. Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C,. 2009. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47: 5-14.
11. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J, Zhang C,. 2010. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87: 431-439.
12. Djordjevic VB, Zvezdanovic L, Cosic V,. 2008. Oxidative stress in human diseases. Srp Arh Celok Lek 136 (Suppl 2): 158-165.
13. Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C,. 2009. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284: 29514-29525.
14. Filipowicz W, Bhattacharyya SN, Sonenberg N,. 2008. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight ? Nat Rev Genet 9: 102-114.
15. Flynt AS, Li N, Thatcher EJ, Solnica-Krezel L, Patton JG,. 2007. Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat Genet 39: 259-263.
16. Glass C, Singla DK,. 2011. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am J Physiol Heart Circ Physiol 301: H2038-H2049.
17. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C,. 2007. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588.
18. Jia LQ, Yang GL, Ren L, Chen WN, Feng JY, Cao Y, Zhang L, Li XT, Lei P,. 2012. Tanshinone IIA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells. J Ethnopharmacol 143: 100-108.
19. Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS,. 2003. H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 35: 615-621.
20. Lefer DJ, Granger DN,. 2000. Oxidative stress and cardiac disease. Am J Med 109: 315-323.
21. Lewis BP, Burge CB, Bartel DP,. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
22. Mak LH, Vilar R, Woscholski R,. 2010. Characterisation of the PTEN inhibitor VO-OHpic. J Chem Biol 3: 157-163.
23. Martindale JL, Holbrook NJ,. 2002. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 192: 1-15.
24. Mocanu MM, Yellon DM,. 2007. PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury ? Br J Pharmacol 150: 833-838.
25. Narducci MG, Arcelli D, Picchio MC, Lazzeri C, Pagani E, Sampogna F, Scala E, Fadda P, Cristofoletti C, Facchiano A, Frontani M, Monopoli A, Ferracin M, Negrini M, Lombardo GA, Caprini E, Russo G,. 2011. MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome. Cell Death Dis 2: e151.
26. Pratico D, Delanty N,. 2000. Oxidative injury in diseases of the central nervous system: Focus on Alzheimer's disease. Am J Med 109: 577-585.
27. Rosivatz E,. 2007. Inhibiting PTEN. Biochem Soc Trans 35: 257-259.
28. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M,. 2007. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
29. Schmeier S, Schaefer U, Essack M, Bajic VB,. 2011. Network analysis of microRNAs and their regulation in human ovarian cancer. BMC Syst Biol 5: 183.
30. Seddon M, Looi YH, Shah AM,. 2007. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93: 903-907.
31. Sheng R, Gu ZL, Xie ML, Zhou WX, Guo CY,. 2010. Epigallocatechin gallate protects H9c2 cardiomyoblasts against hydrogen dioxides-induced apoptosis and telomere attrition. Eur J Pharmacol 641: 199-206.
32. Siddall HK, Warrell CE, Yellon DM, Mocanu MM,. 2008. Ischemia-reperfusion injury and cardioprotection: Investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency. Basic Res Cardiol 103: 560-568.
33. Stockert JC, Blazquez-Castro A, Canete M, Horobin RW, Villanueva A,. 2012. MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochem 114: 785-796.
34. Takano H, Zou Y, Hasegawa H, Akazawa H, Nagai T, Komuro I,. 2003. Oxidative stress-induced signal transduction pathways in cardiac myocytes: Involvement of ROS in heart diseases. Antioxid Redox Signal 5: 789-794.
35. Tanaka M, Miyazaki T, Tanigaki S, Kasai K, Minegishi K, Miyakoshi K, Ishimoto H, Yoshimura Y,. 2000. Participation of reactive oxygen species in PGF2alpha-induced apoptosis in rat luteal cells. J Reprod Fertil 120: 239-245.
36. Thannickal VJ, Fanburg BL,. 2000. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028.
37. van Meerloo J, Kaspers GJ, Cloos J,. 2011. Cell sensitivity assays: The MTT assay. Methods Mol Biol 731: 237-245.
38. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN,. 2006. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103: 18255-18260.
39. Vandenbroucke K, Robbens S, Vandepoele K, Inze D, Van de Peer Y, Van Breusegem F,. 2008. Hydrogen peroxide-induced gene expression across kingdoms: A comparative analysis. Mol Biol Evol 25: 507-516.
40. Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, Fan GC,. 2010. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122: 1308-1318.
41. 2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med 33: 1419-1432.
42. Wetzker R, Rommel C,. 2004. Phosphoinositide 3-kinases as targets for therapeutic intervention. Curr Pharm Des 10: 1915-1922.
43. Xia H, Ooi LL, Hui KM,. 2012. MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS ONE 7: e44206.
44. Xiong X, Ren HZ, Li MH, Mei JH, Wen JF, Zheng CL,. 2011. Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein. Pathol Oncol Res 17: 931-937.
45. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z,. 2007. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491.
46. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ,. 2008. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433.
47. Zhang C,. 2008. MicroRNAs: Role in cardiovascular biology and disease. Clin Sci (Lond) 114: 699-706.